The short version of mass spectrometry fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-22 and is reviewed periodically as new material appears.
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | Derived from angiotensin IV and modified for stability. |
| Proposed mechanism | c-Met/HGF pathway activation | Described as an HGF mimetic in experimental systems. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Name usage varies by supplier and publication. |
| Regulatory status | Not approved as a drug | Sold as a research chemical in some markets. |
| Human trial data | Limited or absent | Most evidence comes from preclinical studies. |
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
Myelin has two important advantages: fast conduction speed and energy efficiency. For axons larger than a minimum diameter (roughly 1 micrometre), myelination increases the conduction velocity of an action potential, typically tenfold. Conversely, for a given conduction velocity, myelinated fibers are smaller than their unmyelinated counterparts. For example, action potentials move at roughly the same speed (25 m/s) in a myelinated frog axon and an unmyelinated squid giant axon, but the frog axon has a roughly 30-fold smaller diameter and 1000-fold smaller cross-sectional area. Also, since the ionic currents are confined to the nodes of Ranvier, far fewer ions "leak" across the membrane, saving metabolic energy. This saving is a significant selective advantage, since the human nervous system uses approximately 20% of the body's metabolic energy. The length of axons' myelinated segments is important to the success of saltatory conduction. They should be as long as possible to maximize the speed of conduction, but not so long that the arriving signal is too weak to provoke an action potential at the next node of Ranvier. In nature, myelinated segments are generally long enough for the passively propagated signal to travel for at least two nodes while retaining enough amplitude to fire an action potential at the second or third node. Thus, the safety factor of saltatory conduction is high, allowing transmission to bypass nodes in case of injury.
The reason why α-amino acids are used in proteins has been linked to their frequency in meteorites and prebiotic experiments. An initial speculation on the deleterious properties of β-amino acids in terms of secondary structure turned out to be incorrect.
==== Renovation ==== In 1983, in an attempt to draw crowds to the park and raise money for continued maintenance, the BPRC proposed leasing Bryant Park from the city, renovating it, and building a café in the park. The $18 million renovation was to be executed by an alliance between the BPRC, NYPL, and NYC Parks. Restaurateur Warner LeRoy was to operate the eatery, and he planned to build an 80-foot-tall (24 m), 10,500-square-foot (980 m2) glass café on the park's east side adjacent to the library. In addition, the park would include four smaller food kiosks, a reflecting pool and water fountain, and a dedicated security team.
2020, A. T. Williams, C. R. Muller, A. M. Eaker, D. A. Belcher, C. Bolden-Rush, A. F. Palmer, P. Cabrales, “Polymerized hemoglobin with increased molecular size reduces toxicity in healthy guinea pigs,” ACS Applied Bio Materials Apr 14 3, 5:2976–2985. 2020, A. T. Williams, A. Lucas, C. R. Muller, C. Bolden-Rush, A. F. Palmer, P. Cabrales, “Balance between oxygen transport and blood rheology during resuscitation from hemorrhagic shock with polymerized hemoglobin,” Journal of Applied Physiology Jul 1;129(1):97-107. 2021, C. R. Muller, A. Lucas, V. Courelli, A. T. Williams, F. Dos Santos, C. Cuddington, S. Moses, A. F. Palmer, E. Kistler, P. Cabrales, “Resuscitation from hemorrhagic shock after traumatic brain injury with polymerized hemoglobin,” Scientific Reports Jan 28;11(1):2509. Facilitated oxygen transport Palmer's research focuses on approaches to better improve oxygen storage and transport to cultured cells, especially cells grown in bioreactors. Supporting Publications:
In his book TiHKAL (Tryptamines I Have Known and Loved) and other publications, Alexander Shulgin lists DMT's dose as greater than 350 mg orally, 60 to 100 mg intramuscularly, subcutaneously, or via smoking, and 4 to 30 mg by intravenous injection. He also reported that doses of 150 to 350 mg or even up to 1,000 mg orally and a dose of 100 mg buccally produced no effects, whereas doses of 20 to 80 mg intramuscularly, 30 to 100 mg smoked, and 15 to 30 mg intravenously were all active in producing effects. In terms of intramuscular injection, threshold effects occur at a dose of 30 mg and full effects occur at a dose of 50 to 100 mg by this route. Similarly, the dose for full effects with subcutaneous injection is likewise 60 to 100 mg. With regard to intravenous injection, a dose of 4 mg was indistinguishable from placebo, 8 mg produced physical effects but no psychoactive effects, 15 mg produced threshold psychedelic effects, and 30 mg produced strong psychedelic effects. Shulgin lists the duration of parenteral DMT alone as up to 1 hour. In other more recent publications, different dose ranges of inhaled DMT of 2 to 100 mg or 15 to 60 mg have been described and typical doses have been reported to be 40 to 50 mg. Concerning intravenous injection and based on contemporary clinical studies, 15 mg has been described as a low dose, 25 mg as an intermediate or "good effect" dose, and 30 mg as a high or "ego-dissolution" dose. There may be a ceiling in the intensity of DMT's effects however, with saturation reached at doses of 15 to 20 mg.
Sources: en.wikipedia.org
Martin, Commander of the United States Sixth Fleet from 1983–85; the A-6 Intruder was planned to leave service in 1999, and to be replaced by the AFX, which was cancelled in 1991. Narrated by Bob Peck, directed by Gary Johnstone, produced by Patrick Uden, made by Uden Associates, originally a Nova documentary 24 October Out of the Past, how the Maya civilization collapsed; The world's population was 5 billion - it was 2 billion 50 years before; archaeologists William T. Sanders and William Fash, and the Maya civilization at Copán, in what is now mostly Guatemala; archaeologists William D. Like and Rebecca Storey. Narrated by Jill Dando, and made with Pennsylvania State University. An American production, produced by Sam Low, made by the Cambridge Studios of WQED 31 October Memories Are Made of This, the biochemical mechanism of memory, with memory dysfunction at St Andrew's Hospital in Northampton, and infant studies by Gary Lynch (neuroscientist) at University of California, Irvine, and Portuguese neuroscientist Alcino J. Silva at Cold Spring Harbor Laboratory had found genes for long-term memory; Alan Baddeley of the University of Cambridge; Carolyn Rovee-Collier of Rutgers University; Charles A. Nelson III of the University of Minnesota; Marigold Linton of the University of Arizona; neurobiologist James McGaugh.
The role of FICD in BiP AMPylation (and de-AMPylation) on Thr518 is well supported by biochemical and structural studies. Evidence has also been presented that in some circumstances FICD may AMPylate a different residue, Thr366 in BiP's nucleotide binding domain.
=== International calls for investigations === In April 2020, Australian foreign minister Marise Payne and Australian prime minister Scott Morrison called for an independent international inquiry into the origins of the coronavirus pandemic. A few days later, German chancellor Angela Merkel also pressed China for transparency about the origin of the coronavirus, following similar concerns raised by the French president Emmanuel Macron. The UK also expressed support for an investigation, although both France and UK said the priority at the time was to first fight the virus. Some public health experts have also called for an independent examination of COVID-19's origins, "arguing WHO does not have the political clout to conduct such a forensic analysis". In May 2021, Prime Minister Justin Trudeau told reporters Canada would "support the call by the United States and others to better understand the origins of COVID-19." In June 2021, at the G7 summit in Cornwall, the attending leaders issued a joint statement calling for a new investigation, citing China's refusal to cooperate with certain aspects of the original WHO-convened study. This resistance to international pressure was one of the key findings of a Wall Street Journal investigation into the pandemic origin. The divisive nature of the debate has led scientists to call for less political pressure on the topic.
An active celebrity in the climate change movement, DiCaprio believes global warming is the world's "number-one environmental challenge". Eager to learn about ecology from an early age, he would watch documentaries on rainforest depletion and the loss of species and habitats. In 1998, he established the Leonardo DiCaprio Foundation, a non-profit organization devoted to promoting environmental awareness. It supports organizations and campaigns committed to ensuring a viable future for planet Earth, and produced the short web documentaries Water Planet and Global Warning. The foundation has also funded debt-for-nature swaps. By 2018, the foundation had funded more than 200 projects, providing $100 million in support. He has been an active supporter of numerous environmental organizations and sat on the board of the World Wildlife Fund and International Fund for Animal Welfare. DiCaprio has owned environment-friendly electric-hybrid vehicles. His use of private jets and large yachts have been criticized as hypocritical due to their large carbon footprints. DiCaprio chaired the national Earth Day celebration in 2000 where he interviewed Bill Clinton and they discussed plans to deal with global warming and the environment. He presented at the 2007 American leg of Live Earth. DiCaprio donated $1 million to the Wildlife Conservation Society at Russia's Tiger Summit. DiCaprio's persistence in reaching the event after encountering two plane delays caused then Prime Minister Vladimir Putin to describe him as a "muzhik" or "real man".
=== Discrete pathophysiology and CTS === Hereditary neuropathy with susceptibility to pressure palsies is a genetic condition that appears to increase the probability of developing CTS. Heterozygous mutations in the gene SH3TC2, associated with Charcot-Marie-Tooth, may confer susceptibility to neuropathy, including CTS. Association between common benign tumors such as lipomas, ganglion, and vascular malformation should be handled with care. Such tumors are very common and are more likely to compress the median nerve. Similarly, the association between transthyretin amyloidosis-associated polyneuropathy and carpal tunnel syndrome is under investigation. Prior carpal tunnel release is often noted in individuals who later present with transthyretin amyloid-associated cardiomyopathy. There is consideration that bilateral carpal tunnel syndrome could be a reason to consider amyloidosis, timely diagnosis of which could improve heart health. Amyloidosis is rare, even among people with carpal tunnel syndrome (0.55% incidence within 10 years of carpal tunnel release). In the absence of other factors associated with a notable probability of amyloidosis, it is not clear that biopsy at the time of carpal tunnel release has a suitable balance between potential harms and potential benefits. Other specific pathophysiologies that can cause CTS via pressure include:
Sources: en.wikipedia.org
== D == Dakin reaction (AKA Dakin oxidation) Dakin–West reaction Danheiser annulation Danheiser benzannulation Darapsky degradation Darzens condensation, Darzens–Claisen reaction, Glycidic ester condensation Darzens halogenation Darzens synthesis of unsaturated ketones Darzens tetralin synthesis Davis' reagent, Davis oxidation Davis–Beirut reaction De Kimpe aziridine synthesis Dehydration reaction Dehydrogenation Delépine reaction DeMayo reaction Demjanov rearrangement Demjanow desamination Dess–Martin oxidation Diazoalkane 1,3-dipolar cycloaddition Diazotisation DIBAL-H selective reduction Dieckmann condensation Dieckmann reaction Diels–Alder reaction Diels–Reese reaction Dienol–benzene rearrangement Dienone–phenol rearrangement Dimroth rearrangement Di-π-methane rearrangement Directed ortho metalation Doebner modification Doebner reaction Doebner–Miller reaction, Beyer method for quinolines Doering–LaFlamme carbon chain extension Dötz reaction Dowd–Beckwith ring expansion reaction Duff reaction Dutt–Wormall reaction Dyotropic reaction
Tenascin X (TN-X), also known as flexillin or hexabrachion-like protein, is a 450 kDa glycoprotein, a member of the tenascin family, that is expressed in connective tissues. In humans it is encoded by the TNXB gene. The TN-X protein is expressed in many parts of the human body, including the skin, muscles, kidneys, blood vessels, and digestive tract. Deficiencies in the TN-X protein due to mutations or not enough of it being produced (haploinsufficiency) can lead to a rare condition called classical-like Ehlers–Danlos syndrome (EDS). People with EDS may have loose joints and weak tissues because their bodies make defective collagen.
The most common side effects of benzodiazepines are related to their sedating and muscle-relaxing action. They include drowsiness, dizziness, and decreased alertness and concentration. Lack of coordination may result in falls and injuries, particularly in the elderly. Another result is impairment of driving skills and increased likelihood of road traffic accidents. Decreased libido and erection problems are a common side effect. Depression and disinhibition may emerge. Hypotension and suppressed breathing (hypoventilation) may be encountered with intravenous use. Less common side effects include nausea and changes in appetite, blurred vision, confusion, euphoria, depersonalization and nightmares. Cases of liver toxicity have been described but are very rare. The long-term effects of benzodiazepine use can include cognitive impairment as well as affective and behavioural problems. Feelings of turmoil, difficulty in thinking constructively, loss of sex drive, agoraphobia and social phobia, increasing anxiety and depression, loss of interest in leisure pursuits and interests, and an inability to experience or express feelings can also occur. Not everyone, however, experiences problems with long-term use. Additionally, an altered perception of self, environment and relationships may occur. A study published in 2020 found that long-term use of prescription benzodiazepines is associated with an increase in all-cause mortality among those age 65 or younger, but not those older than 65.
Enfortumab vedotin, sold under the brand name Padcev, is an antibody-drug conjugate used for the treatment of urothelial cancer. It is a nectin-4-directed antibody and microtubule inhibitor conjugate. Enfortumab refers to the monoclonal antibody part, and vedotin refers to the payload drug (MMAE) and the linker. The most common side effects include fatigue, peripheral neuropathy (nerve damage resulting in tingling or numbness), decreased appetite, rash, alopecia (hair loss), nausea, altered taste, diarrhea, dry eye, pruritus (itching) and dry skin. The fully humanized antibody was created by scientists at Agensys (part of Astellas) using Xenomice from Amgen; the linker technology holding the antibody and the toxin together was provided by and licensed from Seattle Genetics. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
The party manifesto resists expanding gender definitions and opposes their integration into school curriculums and government documents and official medical records, positioning its stance as a defence of traditional values and cultural norms. Some of the leader's comments on the "woke agenda" have been perceived by some as transphobic, misogynistic, and as employing dog-whistle rhetoric, whilst Latinopoulou has previously made remarks associating homosexuality with paedophilia amongst some gay rights activists as being a secret Trojan horse method for masking secret pedophilia legalization desires within the gay rights movement for some woke agenda advocates. On the Gaza war, the party supports Israel and condemned the October 7th attack as an attack on Western civilisation, though Latinopoulou later emphasized that both sides should respect the rules of war, particularly considering the safety of women and children. The party also condemned the April 2024 Iranian strikes on Israel. The party condemned the court ban on the Spartans political party in contesting in the 2024 European Parliament election in Greece as a violation of free elections and democratic rights and the setting of a dangerous legal precedent. The party supports the death penalty for heinous crimes such as murder, child rape and sex trafficking where and when evidence is overwhelming, which party leader Latinopoulou has repeatedly voiced support for in public interviews.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide derived from angiotensin IV and studied for effects on synaptic plasticity. It is often described as a hepatocyte growth factor mimetic. It is not an approved medication.
It is based on angiotensin IV, a naturally occurring peptide fragment, but dihexa itself is chemically modified and synthetic. The modifications aim to improve stability and activity compared with the parent fragment.
Laboratory studies have used cell-based assays and rodent models. These examine receptor signaling, dendritic spine changes, and behavioral tasks. Published human clinical trial data are lacking.
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.